Panacea Biotec gets UDFDA approval for supply of Azacitidine Injection to US market

Panacea Biotec's Oncology Parenteral Formulation Facility at Baddi, Himachal Pradesh, India, received United States Food & Drug Administration (USFDA) approval for manufacture and supply of Azacitidine Injection, 100 mg/vial, for the US market.

Panacea Biotec's state-of-the-art pharmaceutical formulation facility at Baddi is already approved by National Regulatory Authority (NRA) of India and USFDA for other oral solids and injectable products.

Powered by Capital Market - Live News